Glioblastoma Neurovascular Progenitor Orchestrates Tumor Cell Type Diversity
Fazzari, E.; Azizad, D. J.; Yu, K.; Ge, W.; Li, M. X.; Nano, P. R.; Kan, R. L.; Tum, H. A.; Tse, C.; Bayley, N. A.; Haka, V.; Cadet, D.; Perryman, T.; Soto, J. A.; Wick, B.; Raleigh, D. R.; Crouch, E. E.; Patel, K. S.; Liau, L. M.; Deneen, B.; Nathanson, D. A.; Bhaduri, A.
Show abstract
Glioblastoma (GBM) exhibits developmental programs and marked cellular heterogeneity, yet how these features are organized into connected lineage hierarchies remains unclear. Here we identify a rare tumor-intrinsic population, termed the neurovascular progenitor (NVP), that occupies an intermediate position between the major GBM organizational axes. NVP cells co-express neural progenitor and perivascular transcriptional features, are consistently detected across independent patient cohorts, retain canonical GBM copy-number alterations, and localize in situ in both vessel-associated and parenchymal niches. Using direct-from-patient lineage tracing in a human organoid tumor transplantation system, we show that individual NVP cells clonally generate both neural-like and mesenchymal/vascular-like malignant progeny, providing a concrete lineage link between states that are commonly considered mutually exclusive. Despite comprising [~]1% of tumor cells, NVP-derived lineages account for a majority of observed tumor cell types and disproportionately contribute to cycling compartments. Orthogonally, ablation of NVP-associated programs in an in vivo GBM model remodels tumor composition, elicits compensatory progenitor states, and significantly prolongs survival. Together, these findings position NVP as a fate-restricted yet highly influential lineage intermediate that serves as a functional bridge and organizational nexus within GBM hierarchies, linking population-level lineage architecture to the behavior of a specific progenitor cell type.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Cellular senescence in malignant cells promotes tumor progression in mouse and patient Glioblastoma 96%
- Drug and single-cell gene expression integration identifies sensitive and resistant glioblastoma cell populations 96%
- Agonistic CD40 antibody therapy induces tertiary lymphoid structures but impairs the response to immune checkpoint blockade in glioma 95%
Similar papers in this journal
Similar papers in this journal
- Single-nucleus and spatial landscape of the sub-ventricular zone in human glioblastoma 98%
- The expression profile and tumorigenic mechanisms of CD97 (ADGRE5) in glioblastoma render it a targetable vulnerability 96%
- NRCAM variant defined by microexon skipping is a targetable cell surface proteoform in high-grade gliomas 95%
Similar papers in this journal
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.